Skip navigation
User training | Reference and search service

Library catalog

Retrievo
EDS
b-on
More
resources
Content aggregators
Please use this identifier to cite or link to this item:

acessibilidade

http://hdl.handle.net/10071/20096
Full metadata record
acessibilidade
DC FieldValueLanguage
dc.contributor.authorYang, M.-
dc.contributor.authorBento, P.-
dc.contributor.authorAkbar, A.-
dc.date.accessioned2020-03-16T09:45:08Z-
dc.date.available2020-03-16T09:45:08Z-
dc.date.issued2019-
dc.identifier.issn2071-1050-
dc.identifier.urihttp://hdl.handle.net/10071/20096-
dc.description.abstractThis research is carried out in the backdrop of increasing product quality and environmental degradation scandals associated with Chinese Pharmaceuticals in recent years. We examine the data of 125 Chinese Pharmaceuticals between 2010-2016 to investigate the impact of overall CSR (Corporate Social Responsibility) performance as well as five unique aspects of CSR performance such as shareholders, employees, customers and suppliers, environmental practices, and the society to gauge the impact of these individual dimensions on firm’s financial performance. A mixed method approach is adopted where twenty experts from the Pharmaceutical industry firstly rate the importance of different stakeholder dimensions based on a five-point Lickert scale. Subsequently, the CSR scoring system is developed by incorporating the weighted average of experts’ scores and the performance of CSR indicators obtained from the Hexun CSR rating. The firm performance is measured by Tobin’s Q, ROA, ROE, and EPS ratios. The outcome of panel based regression models reveal that CSR has a positive and significant influence on firm’s financial performance. Moreover, although all the CSR dimensions relate positively to firm performance nonetheless environmental aspect of CSR has the most profound impact on firm performance followed by customer & suppliers, and employees. However, shareholders and society dimensions have relatively lesser influence on firm performance. These results imply that Chinese Pharmaceuticals shall further optimize their CSR performance as it can not only create a favorable brand image for various stakeholders but also results in superior financial performance.eng
dc.language.isoeng-
dc.publisherMDPI-
dc.relation2017WQNCX194-
dc.relationinfo:eu-repo/grantAgreement/FCT/5876/147442/PT-
dc.rightsopenAccess-
dc.subjectCSR dimensionseng
dc.subjectChinese pharmaceuticalseng
dc.subjectMixed-method approacheng
dc.subjectFirm performanceeng
dc.titleDoes CSR Influence firm performance indicators? evidence from Chinese pharmaceutical enterpriseseng
dc.typearticle-
dc.peerreviewedyes-
dc.journalSustainability-
dc.volume11-
dc.number20-
degois.publication.issue20-
degois.publication.titleDoes CSR Influence firm performance indicators? evidence from Chinese pharmaceutical enterpriseseng
dc.date.updated2020-03-16T09:44:22Z-
dc.description.versioninfo:eu-repo/semantics/publishedVersion-
dc.identifier.doi10.3390/su11205656-
dc.subject.fosDomínio/Área Científica::Ciências Sociais::Economia e Gestãopor
iscte.identifier.cienciahttps://ciencia.iscte-iul.pt/id/ci-pub-62684-
iscte.alternateIdentifiers.wosWOS:000498398900113-
iscte.alternateIdentifiers.scopus2-s2.0-85073934740-
Appears in Collections:BRU-RI - Artigos em revistas científicas internacionais com arbitragem científica

Files in This Item:
acessibilidade
File Description SizeFormat 
sustainability-doi_ 10.3390_su11205656.pdfVersão Editora440.56 kBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Currículo DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.